161 research outputs found
Effect of nitrogen on the kinetics of oxide scale growth and of oxygen dissolution in the Ti6242S titanium-based alloy
Titanium-based alloys are increasingly used in aircraft industry due to their good mechanical properties and low density. To reach better efficiencies, the engine design is constantly evolving and the temperature of the combustion chamber is always increasing. Then, surrounding parts are exposed to higher working temperatures and consequently have to cope with more severe oxidation phenomena. For Ti-based alloys, this leads to the formation of an external oxide scale and a large oxygen dissolution in the metal, which may be detrimental for ductility. As nitrogen is the major element of the atmosphere, it seems relevant to study its effect on the oxidation behavior of Ti-6Al-2Sn-4Zr-2Mo-0.1Si titaniumbased alloy used for these applications. Thermogravimetric analyses were carried out at 650 °C for 100 h in synthetic air (20%O2â80%N2) and in a mixture of 20%O2â80%Ar. Results showed that nitrogen decreases the oxidation kinetics by slowing down the oxide scale growth but also by limiting the oxygen dissolution in
the alloy
Late stage CâH activation of a privileged scaffold; synthesis of a library of benzodiazepines
A library of over twenty 5-(2-arylphenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-ones has been formed by a microwave-mediated late-stage palladium-catalysed arylation of 1,4-benzodiazepines using diaryliodonium salts. This can also be applied to nordazepam (7-chloro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one), the active metabolite of diazepam, and subsequent N-alkylation and/or H/D exchange allows further diversification towards elaborated pharmaceuticals and their 3,3'-deuterated analogues
Influence of the ageing conditions and the initial microstructure on the precipitation of α phase in Ti-17 alloy
The precipitation of α phase during ageing was investigated in the near-ÎČ titanium alloy Ti-17 considering either a fully ÎČmetastable initial microstructure or a 35% αprimary + 65% ÎČmetastable initial microstructure. In-situ electrical resistivity and high energy X-ray diffraction measurements revealed the influence of the initial microstructure, with different α morphologies (size and distribution of αprimary), as well as the heating rate on the precipitation sequences and kinetics following the decomposition of the ÎČ-metastable phase. Various amounts of metastable phases (Ïisothermal and αâłisothermal) precipitate in temperature ranges that increase with the heating rate. From temperatures about 500âŻÂ°C, the orthorhombic αâłisothermal structure evolved towards the hexagonal close-packed α as temperature increased. SEM microstructure characterisations showed that slow heating rates promoted a fine and dense α precipitate distribution through the formation of Ïisothermal and/or αâłisothermal, leading to higher hardness values. A higher heating rate restricted the precipitation of αâłisothermal and shifted to the one of α at a higher temperature, leading to coarser precipitates. Furthermore, precipitation kinetics of αâłisothermal/α were quicker considering an initial intragranular α precipitation as compared to α colonies
Progress in the development of non-âBET bromodomain chemical probes
The bromodomain and extra terminal (BET) family of bromodomains have been the focus of extensive research, leading to the development of many potent, selective chem. probes and recent clinical assets. The profound biol. associated with BET bromodomain inhibition has provided a convincing rationale for targeting bromodomains for the treatment of disease. However, the BET family represents just eight of the at least 56 human bromodomains identified to date. Until recently, there has been significantly less interest in non-âBET bromodomains, leaving a vast area of research and the majority of this new target class yet to be thoroughly investigated. It has been widely reported that several non-âBET bromodomain containing. proteins are associated with various diseases including cancer and HIV. Therefore, the development of chem. probes for non-âBET bromodomains will facilitate elucidation of their precise biol. roles and potentially lead to the development of new medicines. This review summarises the progress made towards the development of non-âBET bromodomain chem. probes to date. In addn., we highlight the potential for future work in this new and exciting area
Optimization of a âBump-and-Holeâ Approach to Allele-Selective BET Bromodomain Inhibition
Allele-specific chemical genetics enables selective inhibition within families of highly-conserved proteins. The four BET (bromodomain & extra-terminal domain) proteins â BRD2, BRD3, BRD4 and BRDT bind acetylated chromatin via their bromodomains and regulate processes such as cell proliferation and inflammation. BET bromodomains are of particular interest, as they are attractive therapeutic targets but existing inhibitors are pan-selective. We previously established a bump-&-hole system for the BET bromodomains, pairing a leucine/alanine mutation with an ethyl-derived analogue of an established benzodiazepine scaffold. Here we optimize upon this system with the introduction of a more conservative and less disruptive leucine/valine mutation. Extensive structure-activity-relationships of diverse benzodiazepine analogues guided the development of potent, mutant-selective inhibitors with desirable physiochemical properties. The active enantiomer of our best compound â 9-ME-1 â shows ~200 nM potency, >100-fold selectivity for the L/V mutant over wild-type and excellent DMPK properties. Through a variety of in vitro and cellular assays we validate the capabilities of our optimized system, and then utilize it to compare the relative importance of the first and second bromodomains to chromatin binding. These experiments confirm the primacy of the first bromodomain in all BET proteins, but also significant variation in the importance of the second bromodomain. We also show that, despite having a minor role in chromatin recognition, BRD4 BD2 is still essential for gene expression , likely through the recruitment of non-histone proteins. The disclosed inhibitor:mutant pair provides a powerful tool for future cellular and in vivo target validation studies
Working with argan cake: a new etiology for hypersensitivity pneumonitis
International audienceAbstractBackgroundArgan is now used worldwide in numerous cosmetic products. Nine workers from a cosmetic factory were examined in our occupational medicine department, following the diagnosis of a case of hypersensitivity pneumonitis (HP) related to handling of argan cakes.MethodsOperators were exposed to three forms of argan (crude granulates, powder or liquid) depending on the step of the process. All workers systematically completed standardized questionnaires on occupational and medical history, followed by medical investigations, comprising, in particular, physical examination and chest X-rays, total IgE and a systematic screening for specific serum antibodies directed against the usual microbial agents of domestic and farmerâs HP and antigens derived from microbiological culture and extracts of various argan products. Subjects with episodes of flu-like syndrome several hours after handling argan cakes, were submitted to a one-hour challenge to argan cakes followed by physical examination, determination of Carbon Monoxide Diffusing Capacity (DLCO) and chest CT-scan on day 2, and, when necessary, bronchoalveolar lavage on day 4.ResultsSix of the nine workers experienced flu-like symptoms within 8Â hours after argan handling. After challenge, two subjects presented a significant decrease of DLCO and alveolitis with mild lymphocytosis, and one presented ground glass opacities. These two patients and another patient presented significant arcs to both granulates and non-sterile powder. No reactivity was observed to sterile argan finished product, antigens derived from argan cultures (various species of Bacillus) and Streptomyces marokkonensis (reported in the literature to contaminate argan roots).ConclusionsWe report the first evidence of hypersensitivity pneumonitis related to argan powder in two patients. This implies preventive measures to reduce their exposure and clinical survey to diagnose early symptoms. As exposure routes are different and antibodies were observed against argan powder and not the sterile form, consumers using argan-based cosmetics should not be concerned
Development of a Series of Kynurenine 3-Monooxygenase Inhibitors Leading to a Clinical Candidate for the Treatment of Acute Pancreatitis
Recently,
we reported a novel role for KMO in the pathogenesis
of acute pancreatitis (AP). A number of inhibitors of kynurenine 3-monooxygenase
(KMO) have previously been described as potential treatments for neurodegenerative
conditions and particularly for Huntingtonâs disease. However,
the inhibitors reported to date have insufficient aqueous solubility
relative to their cellular potency to be compatible with the intravenous
(iv) dosing route required in AP. We have identified and optimized
a novel series of high affinity KMO inhibitors with favorable physicochemical
properties. The leading example is exquisitely selective, has low
clearance in two species, prevents lung and kidney damage in a rat
model of acute pancreatitis, and is progressing into preclinical development
Selective small molecule induced degradation of the BET bromodomain protein BRD4
The Bromo- and Extra-Terminal (BET)
proteins BRD2, BRD3, and BRD4
play important roles in transcriptional regulation, epigenetics, and
cancer and are the targets of pan-BET selective bromodomain inhibitor
JQ1. However, the lack of intra-BET selectivity limits the scope of
current inhibitors as probes for target validation and could lead
to unwanted side effects or toxicity in a therapeutic setting. We
designed Proteolysis Targeted Chimeras (PROTACs) that tether JQ1 to
a ligand for the E3 ubiquitin ligase VHL, aimed at triggering the
intracellular destruction of BET proteins. Compound MZ1 potently and
rapidly induces reversible, long-lasting, and unexpectedly selective
removal of BRD4 over BRD2 and BRD3. The activity of MZ1 is dependent
on binding to VHL but is achieved at a sufficiently low concentration
not to induce stabilization of HIF-1α. Gene expression profiles
of selected cancer-related genes responsive to JQ1 reveal distinct
and more limited transcriptional responses induced by MZ1, consistent
with selective suppression of BRD4. Our discovery opens up new opportunities
to elucidate the cellular phenotypes and therapeutic implications
associated with selective targeting of BRD4
- âŠ